Pharma & Healthcare
Levodopa API
- Types
- Purity: ≥98% · Purity:≥99%
- Applications
- Injectable Preparations · Oral Preparations
5 editions23 December 2025
Compare the product scope, applications and research editions relevant to your next decision.
Pharma & Healthcare
5 editions23 December 2025
Pharma & Healthcare
5 editions27 December 2025
Pharma & Healthcare
5 editions20 December 2025
Pharma & Healthcare
5 editions26 December 2025
Pharma & Healthcare
5 editions21 December 2025
Pharma & Healthcare
5 editions29 December 2025
Pharma & Healthcare
5 editions23 December 2025
Pharma & Healthcare
Revcovi (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.
5 editions22 December 2025
Pharma & Healthcare
5 editions29 December 2025
Pharma & Healthcare
5 editions19 December 2025
Pharma & Healthcare
5 editions22 December 2025
Pharma & Healthcare
5 editions2 January 2026